Copyright  © 1994 - 2019    Symsite Research         All rights reserved.

Modra-based hameln rds invests €7m into development and production of medicines


Modra-based hameln rds, which develops and makes strong painkillers and is owned by the Kerstein family of Germany, improved its net profit 57% to €1m and sales 15% to €11.3m last year. It is investing €7m into drug development and production and aims to increase its sales to €25m annually. The investment will increase its payroll from the current 110 by ten. It also makes substances that are made into drugs in plants in Germany and the UK. The Kerstein family sells €60m worth of drugs annually in Germany and the UK. It is not interested in acquiring the Biotika Slovenská Ľupča pharmaceutical plant, due to the high price asked by owners led by Ivan Varga.



Please reload

Táto správa je z Ekonomiky DNES, denného prehľadu najdôležitejších ekonomických správ zo Slovenska.

This news is from the Slovak Business News TODAY, one-page summary of all the important Slovak business news.

Another slide in corruption perception ranking


Slovakia ranks 59th of 180 countries in the latest corruption perception index compiled by Transparency International, down two places from 2018 and d...

László Sólymos (Most-Híd) resigned as Environment Minister


László Sólymos (Most-Híd) resigned as Environment Minister. On Wednesday evening, while under the influence, he attacked a restaurant employee, puttin...

Ďalší pokles v rebríčku vnímania korupcie


Slovensko tento rok skončilo v rebríčku vnímania korupcie od Transparency International na 59. mieste spomedzi 180 krajín, o dve priečky nižšie ako v...

Please reload